Distigmine Bromide

For research use only. Not for therapeutic Use.

  • CAT Number: R014940
  • CAS Number: 15876-67-2
  • Molecular Formula: C22H32Br2N4O4
  • Molecular Weight: 576.33
  • Purity: ≥95%
Inquiry Now

Distigmine Bromide (CAT: R014940) is a medication used to treat conditions characterized by muscle weakness or dysfunction, such as myasthenia gravis. It functions as a reversible acetylcholinesterase inhibitor, preventing the breakdown of acetylcholine, a neurotransmitter crucial for muscle function. By increasing the availability of acetylcholine at the neuromuscular junction, Distigmine Bromide helps improve muscle strength and contraction.


Catalog Number R014940
CAS Number 15876-67-2
Synonyms

Hexamethylenebis[methylcarbamate] 3-Hydroxy-1-methylpyridinium Bromide; 3,3’-[1,6-Hexanediylbis[(methylimino)carbonyl]oxy]bis[1-methyl-pyridinium Dibromide; BC 51; Distigmine Dibromide; Hexamarium; N,N’-Hexamethylenebis(3-N-methylcarbamoxy-1-methylpy

Molecular Formula C22H32Br2N4O4
Purity ≥95%
Target Cholinesterase (ChE)
Storage -20°C
IUPAC Name (1-methylpyridin-1-ium-3-yl) N-methyl-N-[6-[methyl-(1-methylpyridin-1-ium-3-yl)oxycarbonylamino]hexyl]carbamate;dibromide
InChI InChI=1S/C22H32N4O4.2BrH/c1-23-13-9-11-19(17-23)29-21(27)25(3)15-7-5-6-8-16-26(4)22(28)30-20-12-10-14-24(2)18-20;;/h9-14,17-18H,5-8,15-16H2,1-4H3;2*1H/q+2;;/p-2
InChIKey GJHSNEVFXQVOHR-UHFFFAOYSA-L
SMILES C[N+]1=CC=CC(=C1)OC(=O)N(C)CCCCCCN(C)C(=O)OC2=C[N+](=CC=C2)C.[Br-].[Br-]
Reference

<span style=”color:#000000;”><span style=”font-size:12px;”><span style=”font-family:arial,helvetica,sans-serif;”>1.Kobayashi, Kazuki, et al. &quot;Bowel obstruction-induced cholinergic crisis with progressive respiratory failure following distigmine bromide treatment.&quot;&nbsp;<i style=”font-family: Arial, sans-serif; font-size: 13px;”>Chudoku kenkyu: Chudoku Kenkyukai jun kikanshi= The Japanese journal of toxicology</i>&nbsp;29.1 (2016): 26-29.<br />
2.Mohamed, Gehad Genidy, Mahmoud Sabry Rizk, and Eman Yousry Zaky Frag. &quot;Spectrophotometric determination of distigmine bromide, cyclopentolate HCl, diaveridine HCl and tetrahydrozoline HCl via charge transfer complex formation with TCNQ and TCNE reagents.&quot;&nbsp;<i style=”font-family: Arial, sans-serif; font-size: 13px;”>Iranian journal of pharmaceutical research: IJPR</i>&nbsp;14.3 (2015): 701.<br />
3.Izumi, K., et al. &quot;Effects of bethanechol chloride and distigmine bromide on postvoiding residual volume in patients with underactive bladder.&quot;&nbsp;<i style=”font-family: Arial, sans-serif; font-size: 13px;”>Minerva urologica e nefrologica= The Italian journal of urology and nephrology</i>&nbsp;66.4 (2014): 241-247.</span></span></span>

Request a Quote